Medical Imaging & Technology Alliance filed 2 comments on this docket between Mar 27, 2020 and Jun 30, 2020. 0 other organizations filed here. The comment window closed 2219d ago.
The Medical Imaging & Technology Alliance, the leading trade association representing the manufacturers of medical imaging equipment and radiopharmaceuticals, notes the Agency's decision to extend the public comment period for Docket No. FDA-2019-N-5592, and offer the comments attached in support of our initial letter, submitted March 25th.
As the leading trade association representing the manufacturers of medical imaging equipment and radiopharmaceuticals, the Medical Imaging & Technology Alliance (MITA) shares the Food and Drug Administration's (FDA) commitment to innovation, patient safety, and public health. We applaud the recent artificial intelligence (AI) workshop hosted by the FDA and are encouraged by this opportunity to engage with the Agency to promote the safe and effective use of AI technologies. Our comments are attached.
No abstract recorded.
View on regulations.gov →